Cargando…

Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury

Hyperhomocysteinemia (HHcy) has been linked to several clinical manifestations including chronic kidney disease. However, it is not known whether HHcy has a role in the development of acute kidney injury (AKI). In the present study, we reported that HHcy mice developed more severe renal injury after...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Yanjun, Zhen, Xin, Zhu, Fengxin, Hu, Zheng, Lei, Wenjing, Li, Shuang, Zha, Yan, Nie, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332876/
https://www.ncbi.nlm.nih.gov/pubmed/28255274
http://dx.doi.org/10.7150/ijbs.16725
_version_ 1782511611933622272
author Long, Yanjun
Zhen, Xin
Zhu, Fengxin
Hu, Zheng
Lei, Wenjing
Li, Shuang
Zha, Yan
Nie, Jing
author_facet Long, Yanjun
Zhen, Xin
Zhu, Fengxin
Hu, Zheng
Lei, Wenjing
Li, Shuang
Zha, Yan
Nie, Jing
author_sort Long, Yanjun
collection PubMed
description Hyperhomocysteinemia (HHcy) has been linked to several clinical manifestations including chronic kidney disease. However, it is not known whether HHcy has a role in the development of acute kidney injury (AKI). In the present study, we reported that HHcy mice developed more severe renal injury after cisplatin injection and ischemia-reperfusion injury shown as more severe renal tubular damage and higher serum creatinine. In response to cisplatin, HHcy mice showed more prevalent tubular cell apoptosis and decreased tubular cell proliferation. Mechanistically, a heightened ER stress and a reduced Akt activity were observed in kidney tissues of HHcy mice after cisplatin injection. Stimulating cultured NRK-52E cells with Hcy significantly increased the fraction of cells in G2/M phase and cell apoptosis together with decreased Akt kinase activity. Akt agonist IGF-1 rescued HHcy-induced cell cycle arrest and cell apoptosis. In conclusion, the present study provides evidence that HHcy increases the sensitivity and severity of AKI.
format Online
Article
Text
id pubmed-5332876
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-53328762017-03-02 Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury Long, Yanjun Zhen, Xin Zhu, Fengxin Hu, Zheng Lei, Wenjing Li, Shuang Zha, Yan Nie, Jing Int J Biol Sci Research Paper Hyperhomocysteinemia (HHcy) has been linked to several clinical manifestations including chronic kidney disease. However, it is not known whether HHcy has a role in the development of acute kidney injury (AKI). In the present study, we reported that HHcy mice developed more severe renal injury after cisplatin injection and ischemia-reperfusion injury shown as more severe renal tubular damage and higher serum creatinine. In response to cisplatin, HHcy mice showed more prevalent tubular cell apoptosis and decreased tubular cell proliferation. Mechanistically, a heightened ER stress and a reduced Akt activity were observed in kidney tissues of HHcy mice after cisplatin injection. Stimulating cultured NRK-52E cells with Hcy significantly increased the fraction of cells in G2/M phase and cell apoptosis together with decreased Akt kinase activity. Akt agonist IGF-1 rescued HHcy-induced cell cycle arrest and cell apoptosis. In conclusion, the present study provides evidence that HHcy increases the sensitivity and severity of AKI. Ivyspring International Publisher 2017-02-06 /pmc/articles/PMC5332876/ /pubmed/28255274 http://dx.doi.org/10.7150/ijbs.16725 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Long, Yanjun
Zhen, Xin
Zhu, Fengxin
Hu, Zheng
Lei, Wenjing
Li, Shuang
Zha, Yan
Nie, Jing
Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
title Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
title_full Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
title_fullStr Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
title_full_unstemmed Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
title_short Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
title_sort hyperhomocysteinemia exacerbates cisplatin-induced acute kidney injury
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332876/
https://www.ncbi.nlm.nih.gov/pubmed/28255274
http://dx.doi.org/10.7150/ijbs.16725
work_keys_str_mv AT longyanjun hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT zhenxin hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT zhufengxin hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT huzheng hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT leiwenjing hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT lishuang hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT zhayan hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury
AT niejing hyperhomocysteinemiaexacerbatescisplatininducedacutekidneyinjury